Acerus Pharmaceuticals Corporation (TSX:ASP) announced that it has issued a non-brokered private placement of 23,230,772 common share at a price of CAD 0.195 per share for gross proceeds of for gross proceeds of CAD 4,530,001 on March 29, 2019. The transaction included participation from returning investor First Generation Capital Inc. for 15,384,616 common shares. As a part of transaction Ian Ihnatowycz invested through First Generation Capital Inc.